{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:12:16Z","timestamp":1790053936401,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["EDCTP-RegNet 2015-1045"],"award-info":[{"award-number":["EDCTP-RegNet 2015-1045"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Malaria in pregnancy is associated with considerable morbidity and mortality. Regular surveillance of artemisinin-based combination therapy tolerance, or molecular makers of resistance, is vital for effective malaria treatment, control and eradication programmes.\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      multiple drug resistance-1 gene (\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      ) N86Y mutation is associated with reduced susceptibility to lumefantrine. This study assessed the prevalence of\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      N86Y in Brazzaville, Republic of Congo.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total 1001 of\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      -infected blood samples obtained from asymptomatic malaria pregnant women having a normal child delivery at the Madibou Integrated Health Centre were analysed.\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      N86Y genotyping was conducted using PCR-restriction fragment length polymorphism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The wild type\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      N86 allele was predominant (&gt;\u200968%) in this study, whereas a few isolates carrying the either the mutant allele (\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      86Y) alone or both alleles (mixed genotype). The dominance of the wildtype allele (\n                      <jats:italic>pfmdr1<\/jats:italic>\n                      N86) indicates the plausible decline\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      susceptibility to lumefantrine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study gives an update on the prevalence of\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      N86Y alleles in Brazzaville, Republic of Congo. It also raises concern on the imminent emergence of resistance against artemether\u2013lumefantrine in this setting. This study underscores the importance to regular artemether\u2013lumefantrine efficacy monitoring to inform the malaria control programme of the Republic of Congo.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-020-03246-0","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T07:02:59Z","timestamp":1588921379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Molecular surveillance of the Pfmdr1 N86Y allele among Congolese pregnant women with asymptomatic malaria"],"prefix":"10.1186","volume":"19","author":[{"given":"Louis Regis","family":"Dossou-Yovo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4748-050X","authenticated-orcid":false,"given":"Francine","family":"Ntoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Koukouikila-Koussounda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannhey Christevy","family":"Vouvoungui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodele","family":"Adedoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nderu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumalaisamy P.","family":"Velavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e8ne","family":"Lenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"3246_CR1","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015.","edition":"3"},{"key":"3246_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4269\/ajtmh.2001.64.12","volume":"64","author":"JF Trape","year":"2001","unstructured":"Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg. 2001;64:12\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"3246_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"MD Conrad","year":"2019","unstructured":"Conrad MD, Rosenthal PJ. Antimalarial drug resistance in Africa: the calm before the storm? Lancet Infect Dis. 2019;19:338\u201351.","journal-title":"Lancet Infect Dis."},{"key":"3246_CR4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","volume":"19","author":"WL Hamilton","year":"2019","unstructured":"Hamilton WL, Amato R, van der Pluijm RW, Jacob CG, Quang HH, Thuy-Nhien NT, et al. Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study. Lancet Infect Dis. 2019;19:943\u201351.","journal-title":"Lancet Infect Dis."},{"key":"3246_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"3246_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"3246_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.parint.2009.04.004","volume":"58","author":"T Mita","year":"2009","unstructured":"Mita T, Tanabe K, Kita K. Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int. 2009;58:201\u20139.","journal-title":"Parasitol Int"},{"key":"3246_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4269\/ajtmh.2004.70.133","volume":"70","author":"B Nsimba","year":"2004","unstructured":"Nsimba B, Malonga DA, Mouata AM, Louya F, Kiori J, Malanda M, et al. Efficacy of sulfadoxine\/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo. Am J Trop Med Hyg. 2004;70:133\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"3246_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.actatropica.2005.06.001","volume":"95","author":"PI Mayengue","year":"2005","unstructured":"Mayengue PI, Ndounga M, Davy MM, Tandou N, Ntoumi F. In vivo chloroquine resistance and prevalence of the pfcrt codon 76 mutation in Plasmodium falciparum isolates from the Republic of Congo. Acta Trop. 2005;95:219\u201325.","journal-title":"Acta Trop"},{"key":"3246_CR10","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/j.1365-3156.2007.01904.x","volume":"12","author":"M Ndounga","year":"2007","unstructured":"Ndounga M, Tahar R, Basco LK, Casimiro PN, Malonga DA, Ntoumi F. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo. Trop Med Int Health. 2007;12:1164\u201371.","journal-title":"Trop Med Int Health."},{"key":"3246_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.meegid.2015.04.007","volume":"33","author":"F Koukouikila-Koussounda","year":"2015","unstructured":"Koukouikila-Koussounda F, Bakoua D, Fesser A, Nkombo M, Vouvoungui C, Ntoumi F. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo. Infect Genet Evol. 2015;33:32\u20136.","journal-title":"Infect Genet Evol."},{"key":"3246_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1083\/jcb.113.5.1033","volume":"113","author":"AF Cowman","year":"1991","unstructured":"Cowman AF, Karcz S, Galatis D, Culvenor JG. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J Cell Biol. 1991;113:1033\u201342.","journal-title":"J Cell Biol"},{"key":"3246_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12936-015-0791-3","volume":"14","author":"SJ Reiling","year":"2015","unstructured":"Reiling SJ, Rohrbach P. Monitoring PfMDR1 transport in Plasmodium falciparum. Malar J. 2015;14:270.","journal-title":"Malar J."},{"key":"3246_CR14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438\u201347.","journal-title":"Lancet"},{"key":"3246_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1475-2875-8-89","volume":"8","author":"S Picot","year":"2009","unstructured":"Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J. 2009;8:89.","journal-title":"Malar J."},{"key":"3246_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12936-016-1503-3","volume":"15","author":"SD Otienoburu","year":"2016","unstructured":"Otienoburu SD, Maiga-Ascofare O, Schramm B, Jullien V, Jones JJ, Zolia YM, et al. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. Malar J. 2016;15:452.","journal-title":"Malar J."},{"key":"3246_CR17","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1086\/427997","volume":"191","author":"C Sisowath","year":"2005","unstructured":"Sisowath C, Stromberg J, M\u00e5rtensson A, Msellem M, Obondo C, Bjorkman A, et al. In vivo selection of Plasmodium falciparum pfmdr1 86\u00a0N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis. 2005;191:1014\u20137.","journal-title":"J Infect Dis"},{"key":"3246_CR18","doi-asserted-by":"publisher","first-page":"e0151565","DOI":"10.1371\/journal.pone.0151565","volume":"11","author":"P Sondo","year":"2016","unstructured":"Sondo P, Derra K, Diallo Nakanabo S, Tarnagda Z, Kazienga A, Zampa O, et al. Artesunate-amodiaquine and artemether-lumefantrine therapies and selection of Pfcrt and Pfmdr1 alleles in Nanoro, Burkina Faso. PLoS One. 2016;11:e0151565.","journal-title":"PLoS One."},{"key":"3246_CR19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/infdis\/jis747","volume":"207","author":"M Malmberg","year":"2013","unstructured":"Malmberg M, Ferreira PE, Tarning J, Ursing J, Ngasala B, Bjorkman A, et al. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms. J Infect Dis. 2013;207:842\u20137.","journal-title":"J Infect Dis"},{"key":"3246_CR20","doi-asserted-by":"publisher","first-page":"ofwo229","DOI":"10.1093\/ofid\/ofx163.1254","volume":"4","author":"AR Taylor","year":"2017","unstructured":"Taylor AR, Flegg JA, Holmes CC, Gu\u00e9rin PJ, Sibley CH, Conrad MD, et al. Artemether-lumefantrine and dihydroartemisinin-piperaquine exert inverse selective pressure on Plasmodium falciparum drug sensitivity-associated haplotypes in Uganda. Open Forum Infect Dis. 2017;4:ofwo229.","journal-title":"Open Forum Infect Dis."},{"key":"3246_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/14787210.2017.1313703","volume":"15","author":"JP Gil","year":"2017","unstructured":"Gil JP, Krishna S. Pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies. Expert Rev Anti Infect Ther. 2017;15:527\u201343.","journal-title":"Expert Rev Anti Infect Ther."},{"key":"3246_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0035-9203(85)90054-9","volume":"79","author":"JF Trape","year":"1985","unstructured":"Trape JF, Peelman P, Morault-Peelman B. Criteria for diagnosing clinical malaria among a semi-immune population exposed to intense and perennial transmission. Trans R Soc Trop Med Hyg. 1985;79:435\u201342.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl 2","key":"3246_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0035-9203(87)90472-X","volume":"81","author":"JF Trape","year":"1987","unstructured":"Trape JF, Zoulani A. Malaria and urbanization in central Africa: the example of Brazzaville. Part II: results of entomological surveys and epidemiological analysis. Trans R Soc Trop Med Hyg. 1987;81(Suppl 2):10\u20138.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"3246_CR24","volume-title":"Politique nationale de lutte contre le paludisme","author":"Minist\u00e8re de la Sant\u00e9 et de la Population","year":"2006","unstructured":"Minist\u00e8re de la Sant\u00e9 et de la Population. Politique nationale de lutte contre le paludisme. Brazzaville: Republic of Congo; 2006."},{"key":"3246_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.actatropica.2018.04.012","volume":"183","author":"NSG Gueye","year":"2018","unstructured":"Gueye NSG, Ntoumi F, Vouvoungui C, Kobawila SC, Nkombo M, Mouanga AM, et al. Plasmodium falciparum merozoite protein-1 genetic diversity and multiplicity of infection in isolates from Congolese children consulting in a pediatric hospital in Brazzaville. Acta Trop. 2018;183:78\u201383.","journal-title":"Acta Trop"},{"key":"3246_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.4269\/ajtmh.2010.10-0339","volume":"83","author":"M Mungthin","year":"2010","unstructured":"Mungthin M, Khositnithikul R, Sitthichot N, Suwandittakul N, Wattanaveeradej V, Ward SA, et al. Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum. Am J Trop Med Hyg. 2010;83:1005\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"3246_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12936-017-1816-x","volume":"16","author":"F Koukouikila-Koussounda","year":"2017","unstructured":"Koukouikila-Koussounda F, Jeyaraj S, Nguetse CN, Nkonganyi CN, Kokou KC, Etoka-Beka MK, et al. Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy. Malar J. 2017;16:155.","journal-title":"Malar J."},{"key":"3246_CR28","unstructured":"ACT Partner Drug Molecular Surveyor. (https:\/\/www.wwarn.org\/tracking-resistance\/act-partner-drug-molecular-surveyor)."},{"key":"3246_CR29","unstructured":"Plasmodium falciparum Community Project. (www.malariagen.net\/projects\/p-falciparum-community-project)."},{"key":"3246_CR30","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gnadig N, Uhlemann AC, et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7:11553.","journal-title":"Nat Commun."},{"key":"3246_CR31","doi-asserted-by":"publisher","first-page":"e000999","DOI":"10.1136\/bmjgh-2018-000999","volume":"3","author":"LC Okell","year":"2018","unstructured":"Okell LC, Reiter LM, Ebbe LS, Baraka V, Bisanzio D, Watson OJ, et al. Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa. BMJ Glob Health. 2018;3:e000999.","journal-title":"BMJ Glob Health."},{"key":"3246_CR32","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","volume":"91","author":"M Venkatesan","year":"2014","unstructured":"Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg. 2014;91:833\u201343.","journal-title":"Am J Trop Med Hyg."},{"key":"3246_CR33","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1365-2958.2004.04470.x","volume":"55","author":"R Hayward","year":"2005","unstructured":"Hayward R, Saliba KJ, Kirk K. Pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol Microbiol. 2005;55:1285\u201395.","journal-title":"Mol Microbiol"},{"key":"3246_CR34","first-page":"7071383","volume":"2018","author":"MN Moyeh","year":"2018","unstructured":"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, et al. Effects of drug policy changes on evolution of molecular markers of Plasmodium falciparum resistance to chloroquine, amodiaquine, and sulphadoxine-pyrimethamine in the South West Region of Cameroon. Malar Res Treat. 2018;2018:7071383.","journal-title":"Malar Res Treat."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03246-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-020-03246-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03246-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T19:14:08Z","timestamp":1620414848000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03246-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3246"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03246-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.17894\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17894\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17894\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17894\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"23 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Ethics Committee of Fondation Congolaise pour la Recherche M\u00e9dicale, FCRM, Brazzaville, Republic of Congo. Written informed consent was obtained from all participants before samples collection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}